🇺🇸 FDA
Patent

US 7887836

Compositions and methods for treating lymphoma

granted A61KA61K31/475A61K31/704

Quick answer

US patent 7887836 (Compositions and methods for treating lymphoma) held by The Board of Regents of the University of Texas System expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Feb 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K31/475, A61K31/704, A61K9/127, A61K9/1278